Back to search

National and Kapodistrian University of Athens

Διερεύνηση των κλινικών και οικονομικών συνεπειών από τη χρήση των ΠΕΚΦΚ και των ΠΕΚΦΚ που συνδέονται με ενταφιαζόμενο κώδωνα χημειοθεραπείας

Abstract

dc:description

ABSTRACT Introduction: Peripherally inserted central catheters (PICCs) and PICC-port systems are used for the administration of anticancer treatment. However, they differ in terms of insertion technique, patient experience, follow-up requirements, complications, and direct insertion cost. Aim: The aim of this study was to compare PICCs and PICC-port systems regarding patient experience, technical insertion characteristics, documented complications and device dysfunctions, follow-up requirements, and direct insertion cost in adult oncology patients. Materials and Methods: A retrospective comparative cohort study was conducted among 164 adult oncology patients, of whom 101 had a PICC and 63 had a PICC-port inserted between 2015 and 2020. Categorical variables were compared using the chi-square test or Fisher’s exact test, while continuous or ordinal variables were compared using the independent-samples t-test or the Mann–Whitney U test, according to their distribution. A secondary composite pain–difficulty score was developed from four individual items and demonstrated acceptable internal consistency (Cronbach’s α= 0.798). Supplementary simple linear regression models were also performed, with catheter type as the sole independent variable. Results: The two groups did not differ significantly in the recorded demographic and basic clinical characteristics. Patients with a PICC reported lowerpain during device insertion and removal, greater comfort during insertion, and less difficulty during device removal compared with patients with a PICC-port (all p < 0.001). The composite pain–difficulty score was also lower in the PICC group. In the simple linear regression model, PICC-port use was associated with a mean 1.676- point higher pain–difficulty score compared with PICC use (95% CI: 1.584–1.768; p <0.001). PICC-port use was also associated with a €68.41 higher direct insertion cost (95% CI: €51.95–€84.87; p < 0.001) and a 3.919 cm longer subcutaneous tunnel length(95% CI: 3.719–4.118; p < 0.001) compared with PICC use. Insertion-related adverse events were documented in 6.3% of patients with a PICC-port and in none of the patients with a PICC (Fisher’s exact test, p = 0.021). All patients required scheduled device follow-up, with planned intervals of seven days for PICCs and 21 days for PICC-port systems. No statistically significant differences were observed between the two groups regarding thrombosis or thrombophlebitis, central line-associated bloodstream infection, catheter-related bloodstream infection, occlusion, accidental device removal, overall device satisfaction, or the need for telephone or in-person contact with the vascular access team following insertion. Conclusions: PICC use was associated with a lower immediate procedurerelated burden, lower direct insertion cost, and a lower documented frequency of insertion-related adverse events compared with PICC-port use. However, these findings were based on unadjusted comparisons and do not establish causal or overall superiority of one catheter type over the other. Device selection should therefore be individualized according to the patient’s clinical condition, the type and anticipated duration of treatment, follow-up requirements, available healthcare resources, and patientpreferences.Keywords: PICC, PICC-port, oncology patients, central venous access, direct insertioncost, patient experience.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Efstathopoulou, Kyparissia-Efthymia
  • Ευσταθοπούλου, Κυπαρισσία-Ευθυμία

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/62678

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Efstathopoulou, Kyparissia-Efthymia; Ευσταθοπούλου, Κυπαρισσία-Ευθυμία. Διερεύνηση των κλινικών και οικονομικών συνεπειών από τη χρήση των ΠΕΚΦΚ και των ΠΕΚΦΚ που συνδέονται με ενταφιαζόμενο κώδωνα χημειοθεραπείας. National and Kapodistrian University of Athens, 2026. http://hdl.handle.net/10442/hedi/62678